Enjoy complimentary customisation on priority with our Enterprise License!
The aneurysm coiling and embolization devices market share is expected to increase by USD 1.87 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 9.06%. This aneurysm coiling and embolization devices market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. The aneurysm coiling and embolization devices market report also offers information on several market vendors, including Acandis GmbH, Asahi Intecc Co. Ltd., B Braun Melsungen AG, BALT Group, Braile Biomedica, Cook Group Inc., Integer Holdings Corp., Johnson and Johnson, Kaneka Corp., Lepu Medical Technology Beijing Co. Ltd., MicroPort Scientific Corp., Penumbra Inc., phenox GmbH, Stryker Corp., Terumo Corp., and Medtronic Plc among others. Furthermore, this report extensively covers aneurysm coiling and embolization devices market segmentation by product (embolization coils, access and delivery services, aneurysm clips, balloon and stent assisted coils, and flow diversion devices) and geography (North America, Europe, Asia, and Rest of World (ROW)).
Download the Free Report Sample to Unlock the Aneurysm Coiling and Embolization Devices Market Size for the Forecast Period and Other Important Statistics
The increasing prevalence of IAs and associated risk factors is notably driving the aneurysm coiling and embolization devices market growth, although factors such as high cost of treatment may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the aneurysm coiling and embolization devices industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Aneurysm Coiling and Embolization Devices Market Driver
One of the key factors driving the global aneurysm coiling and embolization devices industry growth is the increasing prevalence of IAs and associated risks. For instance, the global prevalence of IAs is around 75 per every 1,000 individuals, and the annual incidence of reported ruptured aneurysms is about 100 in every million people. The estimated worldwide incidence of subarachnoid hemorrhage (SAH) is 90 per million people per year with regional variation.; 20 out of every 1,000 people in the US will develop an unruptured IA in their lifetime. Furthermore, if a patient has an aneurysm, there is nearly a 20% likelihood that the person will have one or more additional aneurysms. Other risk factors associated with IAs, including hypertension, smoking, and chronic alcohol use, are also on the rise. This, in turn, is leading to an increase in the prevalence of IAs, which will drive market growth in the forecast period.
Key Aneurysm Coiling and Embolization Devices Market Trend
Growing demand for flow diversion as an alternative to neurovascular coiling is one of the key aneurysm coiling and embolization devices market trends that is expected to impact the industry positively in the forecast period. Flow diversion procedures are associated with a low complication rate, high cure rate, and increased safety. Furthermore, they reduce the chances of a patient developing another aneurysm, require a shorter recovery period, and involve lesser radiation exposure when compared with other endovascular techniques. Also, FDS provides better neck reconstruction and reduces the need for retreatment and the rate of long-term recanalization when compared with conventional endovascular embolization with coils alone or coils in combination with stents. Furthermore, the use of FDS such as the Pipeline Embolization Device is more cost-effective than traditional SAC for the treatment of large anterior circulation aneurysms. Hence, the increase in demand for flow diversion procedures will be driving the market growth.
Key Aneurysm Coiling and Embolization Devices Market Challenge
One of the key challenges to the global aneurysm coiling and embolization devices industry growth is the high cost of treatment. In the US, the average one-year total cost for a patient with an IA treated by clipping is around USD 42,000. The average cost of neuroendovascular coiling for a patient with ruptured IA for one year is nearly USD 45,000. The cost of a stent used in SAC is around USD 5,000 to USD 5,500. Patients treated with SAC require significantly more coils than patients who undergo coiling alone. In the US, the hospitalization costs for patients undergoing clipping and coiling of unruptured IAs are significantly higher than Medicare payments. Furthermore, many countries, especially in Asia and MENA (the Middle East and North Africa), offer limited or no reimbursements for neuroendovascular coiling and stenting procedures. Such factors will limit the market growth in the forecast period.
This aneurysm coiling and embolization devices market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global aneurysm coiling and embolization devices market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the aneurysm coiling and embolization devices market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the aneurysm coiling and embolization devices market encompasses successful business strategies deployed by the key vendors. The aneurysm coiling and embolization devices market is fragmented and the vendors are deploying growth strategies such as investment in research and development (R and D) to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The aneurysm coiling and embolization devices market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the aneurysm coiling and embolization devices market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.